Sefin Paediatric Drops is a medicine from Orion Pharma Ltd. It contains cephradine 125 mg/1.25 ml in a 15 ml bottle. It is a first-generation cephalosporin antibiotic used for certain bacterial infections in children.
There are 228 brands of Cephradine listed in Bangladesh. 95 of them have a lower unit price than Sefin. The lowest listed price is Belocef 500 mg Capsule at ৳ 1 per unit.
What is Sefin 125 mg/1.25 ml Paediatric Drops?
Sefin Paediatric Drops is made by Orion Pharma Ltd. The active ingredient is cephradine, which belongs to a group of antibiotics called first-generation cephalosporins. It comes as a liquid drop form, with each 1.25 ml containing 125 mg of cephradine, supplied in a 15 ml bottle. Cephradine works by interfering with the bacterial cell wall, causing the bacteria to break apart. It is used for infections caused by bacteria that are sensitive to it, including some upper and lower respiratory tract infections. This medicine is available only on the prescription of a registered physician.
Uses of Sefin
Sefin Paediatric Drops is used to treat infections caused by bacteria that are sensitive to cephradine. These include upper respiratory tract infections such as sinusitis, pharyngitis, tonsillitis and otitis media, as well as lower respiratory tract infections such as acute and chronic bronchitis and lobar pneumonia. Because it is an antibiotic, it should only be used when prescribed by a doctor for a confirmed or suspected bacterial infection.
How to use Sefin
Give Sefin Paediatric Drops only as your child's doctor has instructed. The doctor decides the dose and the length of the course based on the child's weight, the type of infection and how severe it is. Do not change the dose or stop early unless the doctor says so. The bottle contains a liquid that may need to be prepared as directed; follow the pharmacist's instructions for mixing and storing it. Ask the doctor or pharmacist if you are unsure how to measure or give the drops.
Side effects of Sefin
Most side effects of cephradine involve the stomach and intestines, such as nausea, vomiting, diarrhoea, stomach pain, heartburn or glossitis. Some children may have allergic reactions, including skin rashes, hives, joint pains or swelling, and these are more likely in children who have had allergies, asthma, hay fever or hives before. Dizziness and tightness in the chest have been reported rarely. Contact the doctor if your child has a severe reaction or if side effects do not go away.
Safety and precautions
Sefin Paediatric Drops should not be given to a child who is known or suspected to be allergic to cephalosporin antibiotics. Tell the doctor if your child has had an allergy to penicillins, because there is a risk of cross-sensitivity. Safety in pregnancy has not been established, and cephradine is passed into breast milk, so a doctor should be asked before use in pregnancy or breastfeeding. The doctor should also be told about any kidney problems or other medicines your child is taking, especially other antibiotics or diuretics. Cephradine may cause dizziness, so caution is needed with activities such as cycling or operating machinery. Prolonged use can lead to resistant organisms. Always ask the doctor or pharmacist first.
Frequently asked questions
Is Sefin Paediatric Drops safe in pregnancy or breastfeeding?
Safety in pregnancy has not been established, and cephradine is excreted in breast milk, so it should be used with caution in breastfeeding mothers. A doctor should be asked before this medicine is used during pregnancy or while breastfeeding.
What is Sefin Paediatric Drops used for and what kind of medicine is it?
Sefin Paediatric Drops is a first-generation cephalosporin antibiotic containing cephradine. It is used to treat bacterial infections that are sensitive to cephradine, including some upper and lower respiratory tract infections. It is not for viral infections such as colds.
What do the dosage form and strength of Sefin Paediatric Drops mean?
Sefin Paediatric Drops is a liquid drop form for children. The strength 125 mg/1.25 ml means that each 1.25 ml of the liquid contains 125 mg of cephradine. The bottle contains 15 ml. The doctor decides how much to give.
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
... Read more
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.
Urinary tract infections: cystitis, urethritis and pyelonephritis.
Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.
The following microorganisms are susceptible, in vitro to Cephradine:
Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.
Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephradine which is unaffected by this enzyme.
Pharmacology
Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.
Dosage & Administration
For oral administration- Adults:
Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.
Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.
Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.
Children:
Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.
Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.
Maximum daily dosage: 4 gm
Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.
For injectable administration-
Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.
Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection.
Interaction
The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.
Contraindications
Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.
Side Effects
Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.
Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)
Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis
Renal and urinary disorders- Unknown: Reversible interstitial nephritis
Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase.
Pregnancy & Lactation
Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.
Precautions & Warnings
Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.
Cephradine should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.
Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.
Cephradine may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).
Dosage adjustment is necessary in renal impairment.
This product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Overdose Effects
The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.
Storage Conditions
Cephradine Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephradine Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician
Alternative brands of Cephradine
Other brands with the same generic name, cheapest first.